FDA: Baxter Issues Voluntary Nationwide Recall of Cefazolin in Dextrose Injection, USP, 2G/100 ML Single Dose Infusion Bag
Published: 07/27/2026
Sources:
- Food and Drug Administration
Relevant To:
- Ambulatory Surgical Centers,
- Rural Emergency Hospitals,
- Urgent Care,
- Critical Access Hospitals,
- Hospitals,
- Office-Based Surgery,
- Pharmacy,
- Rural Health Clinics
Baxter International Inc. is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.
- The product is used intravenously to treat bacterial infections or prevent bacterial infections during surgery.
The impacted products were distributed from March 25, 2025 through June 30, 2025.
Affected Product:
|
Product Code |
Product Description |
…